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Table 1. Results of various diagnostic procedures for the detection of Giardia and Cryptosporidium in stool specimen
Giardia Cryptosporidium
True positive True negative True positive True negative
No. of specimens 45 175 17 203
No. of positive specimens by:
O&P microscopy 41 0 na na
DFA Meriﬂuor 42 1 15 0
Rida Quick Giardia 36 1 na na
Rida Quick Cryptosporidium na na 15 0
Rida Quick Combi 36 0 14 0
Ridascreen Giardia 37 2 na na
Ridascreen Cryptosporidium na na 14 0
Giardia-Strip 20 0a na na
Cryptosporidium-Strip na na 12b 3c
na, not applicable.
a Two samples with invalid test result.
b One sample with invalid test result.
c Six samples with invalid test result.
O&P, ova and parasites.
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